Virus News and Research

Latest Virus News and Research

SARS-CoV-2 spike protein can lead to heart muscle injury through the inflammatory process

Heart damage is common among patients hospitalized with COVID-19, leading many to wonder how the virus affects the heart.

25 Jul 2022

How prepared are we for a widespread monkeypox outbreak?

In a new study, researchers summarized the epidemiology, etiology, clinical presentation, diagnosis and prevention and treatment strategies for monkeypox (MPX) caused by the monkeypox virus (MPXV).

25 Jul 2022

New RT-PCR platform gives results faster than other COVID-19 tests on the market

For more than 30 years, polymerase chain reaction (PCR) has been the gold standard in molecular diagnostic testing, detecting genetic material, such as those from a virus or from human DNA.

25 Jul 2022

Study provides the crucial antigenic map of SARS-CoV-2 variants of concern

Twenty different COVID-19 variants were effectively identified and neutralized after a third booster, according to the new study for which the University of Surrey provided the crucial antigenic map of variants of concern.

25 Jul 2022

MolGen showcases its lab automation solutions at AACC in Chicago

MolGen B.V. of Veenendaal (NL), a global solutions provider of hardware, reagents, consumables, software and service for human and animal diagnostics, the agriculture and biotech industries, participates in the American Association for Clinical Chemistry Fair (AACC) in Chicago on July 24th - 28th, 2022.

From MolGen 25 Jul 2022

Maternal antibodies may play a key role in protecting infants from congenital HCMV infections

Antibodies that summon virus-engulfing white blood cells may play an important role in protecting infants from potentially serious congenital infection with human cytomegalovirus (HCMV), according to a study led by an investigator at Weill Cornell Medicine and NewYork-Presbyterian.

22 Jul 2022

Antibodies' neutralization efficacy against Omicron variants BA.1 And BA.2 wanes rapidly, study finds

The Omicron variant of the SARS-CoV-2 virus was first detected in South Africa in November 2021. The high level of infectiousness of the virus and its ability to quickly spawn additional variants has also been observed in Germany: Since January 2022 the Omicron variant BA.1 has dominated here, followed in subsequent months by the variant BA.2.

22 Jul 2022

Weather factors play a key role in determining the spread of dengue and other viral diseases

Rainfall, temperature and ocean-warming affect mosquito breeding and the viral diseases they spread - study.

22 Jul 2022

Study examines the maintenance of immunity to SARS-CoV-2 after natural infection or post-vaccination

A new study examined the maintenance of memory B cell responses to SARS-CoV-2, the virus that causes COVID-19, after recovery from natural infection or post-vaccination.

22 Jul 2022

Australian researchers develop sprayable coating to shield surfaces from viruses, bacteria

A first-of-its-kind sprayable coating that can prevent the surface spread of infection from bacteria and viruses - including COVID-19 - over a sustained period –– has been developed by a team of Australian researchers.

22 Jul 2022

IUPUI researchers are developing a fast, efficient COVID-19 biosensor

As the BA.5 omicron variant continues to spread, health experts are increasingly preparing for a future in which such COVID-19 variants emerge, surge and recede similar to seasonal flu.

21 Jul 2022

LJI study about common cold coronaviruses may offer clues to how immunity can build up against SARS-CoV-2

For a glimpse into the future of SARS-CoV-2 immunity, scientists at La Jolla Institute for Immunology (LJI) are investigating how the immune system builds its defenses against common cold coronaviruses (CCCs).

21 Jul 2022

New AI software can create proteins that may be useful as vaccines, cancer treatments

Scientists have developed artificial intelligence software that can create proteins that may be useful as vaccines, cancer treatments, or even tools for pulling carbon pollution out of the air.

21 Jul 2022

A different approach to build a more durable, broadly effective COVID-19 vaccine

Researchers at University of California San Diego School of Medicine, with colleagues elsewhere, describe a different way to build a COVID-19 vaccine, one that would, in theory, remain effective against new and emerging variants and could be taken as a pill, by inhalation or other delivery methods.

21 Jul 2022

Virus News and Research

Latest Virus News and Research

SARS-CoV-2 spike protein can lead to heart muscle injury through the inflammatory process

How prepared are we for a widespread monkeypox outbreak?

New RT-PCR platform gives results faster than other COVID-19 tests on the market

Study provides the crucial antigenic map of SARS-CoV-2 variants of concern

MolGen showcases its lab automation solutions at AACC in Chicago

Maternal antibodies may play a key role in protecting infants from congenital HCMV infections

Antibodies' neutralization efficacy against Omicron variants BA.1 And BA.2 wanes rapidly, study finds

Weather factors play a key role in determining the spread of dengue and other viral diseases

Study examines the maintenance of immunity to SARS-CoV-2 after natural infection or post-vaccination

Australian researchers develop sprayable coating to shield surfaces from viruses, bacteria

IUPUI researchers are developing a fast, efficient COVID-19 biosensor

LJI study about common cold coronaviruses may offer clues to how immunity can build up against SARS-CoV-2

New AI software can create proteins that may be useful as vaccines, cancer treatments

A different approach to build a more durable, broadly effective COVID-19 vaccine

Are Mexican free-tailed bats a SARS-CoV-2 reservoir?

Booster vaccination counters the severity of Omicron breakthrough infections

Unlocking the power of proteins to better understand human health

Is monkeypox a global public-health emergency?

High-level resistance of SARS-CoV-2 BA.4 against neutralizing antibodies

COVID vaccines induce memory B and T cells in primary antibody deficient patients

A new way of characterising biomolecules eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in